The Relationship Between Pain, Balance and Gait in People With Chronic Obstructive Pulmonary Disease
NCT ID: NCT04202991
Last Updated: 2022-04-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
43 participants
OBSERVATIONAL
2019-05-01
2019-12-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Understanding Balance Impairment in COPD
NCT05984498
Activity, Balance and COPD (ABCOPD)
NCT04006015
Balance Training in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT01424098
Determinants of Balance in Patients With Chronic Obstructive Pulmonary Disease
NCT05771506
Balance Training in Chronic Obstructive Pulmonary Disease
NCT05972239
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
COPD with pain
People with COPD who also report pain more often than not over the previous 3 months
Exposure - pain
Groups are defined by their naturally occurring exposure to pain or not
COPD with no pain
People with COPD who do not report pain more often than not over the previous 3 months
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exposure - pain
Groups are defined by their naturally occurring exposure to pain or not
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Be 18 years or over at the point of recruitment
* Be able to communicate with good verbal English or use adaptive equipment to communicate.
* Be able to complete test procedures
* Stable COPD (six weeks clear of exacerbation)
* No uncorrected visual or somatosensory disturbance
Exclusion Criteria
* Recent exacerbation of COPD (within the last six weeks)
* Unable to provide written informed consent
* Unable to speak English or no translation options available
* Any other acute health conditions that would make activity unsafe e.g. acute infection, unstable cardiac disease.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
South Tees Hospitals NHS Foundation Trust
OTHER
North Tees and Hartlepool NHS Foundation Trust
OTHER
Teesside University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Samantha Harrison
Principle Lecturer in Research and Innovation
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Samantha L Harrison, PhD
Role: PRINCIPAL_INVESTIGATOR
Teesside University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
South Tees Hospitals NHS Trust
Middlesbrough, , United Kingdom
North Tees Hospitals NHS Trust
Stockton-on-Tees, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
13418ca
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.